Related Experiment Video
Updated: Jul 22, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry
Amrit P Singh1, Elizabeth L Courville1
1Department of Pathology, University of Virginia Health, PO Box 800214, Charlottesville, VA 22908, USA.
Abstract:
Flow cytometry (FC) is a well-established method important in the diagnosis and subclassification of lymphoma. In this article, the role of FC in lymphoma prognostication will be explored, and the clinical role for FC minimal/measurable residual disease testing as a monitoring tool for mature lymphoma will be introduced. Potential pitfalls of monitoring for residual/recurrent disease following immunotherapy will be presented.

